Salipdan, Princess Kate Ella C.
HRN: 25-73-46 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2024
CEFUROXIME 750MG (VIAL)
12/17/2024
12/23/2024
IV
435 Mg
Q8H
PCAP C
Waiting Final Action